About

Publications While At HealthPartners

selected publications

Journal Article

A comparison of continuous glucose monitoring-measured time-in-range 70-180 mg/dL versus time-in-tight-range 70-140 mg/dL. 

Diabetes Technology & Therapeutics. 2024

Continuous glucose monitoring prediction of gestational diabetes mellitus and perinatal complications. 

Diabetes Technology & Therapeutics. 2024

Continuous glucose monitoring profiles in pregnancies with and without gestational diabetes mellitus. 

Diabetes care. 2024

Continuous glucose monitoring-derived differences in pregnancies with and without adverse perinatal outcomes. 

Obstetrics and Gynecology. 2024

Glucose levels measured with continuous glucose monitoring in uncomplicated pregnancies. 

BMJ open diabetes research & care. 2024

A comparison of continuous glucose monitoring estimated hemoglobin A1c in adults with type 1 or type 2 diabetes. 

Diabetes Technology & Therapeutics. 2023

Assessment of the glucose management indicator using different sampling durations. 

Diabetes Technology & Therapeutics. 2023

Discordance between glucose management indicator and glycated hemoglobin in people without diabetes. 

Diabetes Technology & Therapeutics. 2023

The relationship between percent time <70 mg/dL and percent time <54 mg/dL measured by continuous glucose monitoring. 

Diabetes Technology & Therapeutics. 2023

A comparison of postprandial glucose control in the Medtronic advanced hybrid closed-loop system versus 670G. 

Diabetes Technology & Therapeutics. 2022

Impact of temporary glycemic target use in the hybrid and advanced hybrid closed-loop systems. 

Diabetes Technology & Therapeutics. 2022

The optimal duration of a run-in period to initiate continuous glucose monitoring for a randomized trial. 

Diabetes Technology & Therapeutics. 2022

A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial. 

Lancet (London, England). 2021

Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: a randomized clinical trial. 

JAMA. 2021

Glycaemic profiles of diverse patients with type 2 diabetes using basal insulin: MOBILE study baseline data. 

Diabetes, Obesity & Metabolism. 2021

Lived experience of advanced hybrid closed-loop versus hybrid closed-loop: patient-reported outcomes and perspectives. 

Diabetes Technology & Therapeutics. 2021

The effect of discontinuing continuous glucose monitoring in adults with type 2 diabetes treated with basal insulin. 

Diabetes care. 2021

Diabetes telehealth solutions: improving self-management through remote initiation of continuous glucose monitoring. 

Journal of the Endocrine Society. 2020

Contact

full name

P. Calhoun

Quick Info

 

Collaboration

Co-author network

Map of science